The preceding attempts with growth promoters did not filter outside. The new approach employs the gene therapy - injecting a virus which carries a gene which produces alternatively the neurturin growth promoter - to try to obtain the protective protein line where it needed.
None of the first 12 patients to undergo the experiment - at the university of the hospital of university of precipitations of California, San Francisco and Chicago - suffered serious side effects, Dr. Philip Starr of neurosurgeon of UCSF brought back Monday.
One year after treatment, three patients did not show any difference on a standard rating scale of the movement. But the others nine showed an improvement of 38 percent, Starr said a meeting of the American association of the neurological surgeons.
That does not mean the worked therapy, informed Starr. It could have been coincidence; some preceding attempts found the councils similar of the effectiveness, to only fail once put at a more rigorous test.
But the results encouraged enough that the researchers are registered the victims of more than Parkinson - 56 of them - for the next stage of the test. A third of these patients will undergo the surgery of pretence, obtaining the holes did not drill inside their craniums but any gene-bearing virus, to try to tease outside if the therapy really functions.
None of the first 12 patients to undergo the experiment - at the university of the hospital of university of precipitations of California, San Francisco and Chicago - suffered serious side effects, Dr. Philip Starr of neurosurgeon of UCSF brought back Monday.
One year after treatment, three patients did not show any difference on a standard rating scale of the movement. But the others nine showed an improvement of 38 percent, Starr said a meeting of the American association of the neurological surgeons.
That does not mean the worked therapy, informed Starr. It could have been coincidence; some preceding attempts found the councils similar of the effectiveness, to only fail once put at a more rigorous test.
But the results encouraged enough that the researchers are registered the victims of more than Parkinson - 56 of them - for the next stage of the test. A third of these patients will undergo the surgery of pretence, obtaining the holes did not drill inside their craniums but any gene-bearing virus, to try to tease outside if the therapy really functions.
No comments:
Post a Comment